Skip to main content
. 2021 Feb 23;5(6):1009–1020. doi: 10.1002/hep4.1687

FIG. 3.

FIG. 3

AUCs showing the predictive capability of surrogate biomarkers. AUCs are shown for (A) cT1, (B) cT1 IQR, (C) LS, and (D) ELF to identify those who were in biochemical remission at baseline but will experience disease progression and failure to maintain remission at follow‐up.